Recherche avancée
Affichage des résultats 2461 à 2480 sur 8426 au total
-
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.
Floriane Lignet, Sébastien Benzekry, Shelby Wilson, Frédérique Billy, Olivier Saut, Michel Tod, Benoit You, A. Adda Berkane, S. Kassour, M. X. Wei, Emmanuel Grenier, Benjamin Ribba
-
Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.
Tristan Ferry, Agathe Sénéchal, Marie-Claude Gagnieu, André Boibieux, Frédéric Laurent, Thomas Perpoint, Michel Tod, Christian Chidiac
-
A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy.
Benjamin Ribba, Gentian Kaloshi, Mathieu Peyre, Damien Ricard, Vincent Calvez, Michel Tod, Branka Cajavec-Bernard, Ahmed Idbaih, Dimitri Psimaras, Linda Dainese, Johan Pallud, Stéphanie Cartalat-Carel, Jean-Yves Delattre, Jérôme Honnorat, Emmanuel Grenier, François Ducray
-
Prédiction quantitative des interactions médicamenteuses impliquant les cytochromes 3A4 et 2D6 : approche in vivo
Sylvain Goutelle, M. Tod
-
A pharmacodynamic model of ganciclovir antiviral effect and toxicity for lymphoblastoid cells suggests a new dosing regimen to treat cytomegalovirus infection
A. Janoly-Dumenil, I. Rouvet, Nathalie Bleyzac, F. Morfin, Mt. Zabot, M. Tod
-
A Pharmacokinetic-Pharmacodynamic Model for Predicting the Impact of CYP2C9 and VKORC1 Polymorphisms on Fluindione and Acenocoumarol During Induction Therapy
Dr Verstuyft, Xavier Delavenne, Alexandra Rousseau, Annie Robert, Michel Tod, Bertrand Diquet, Martine Lebot, Patrice Jaillon, Laurent Becquemont
-
Model-based design of rituximab dosing optimization in follicular non-hodgkin lymphoma
David Ternant, Guillaume Cartron, E. Henin, Michel Tod, Pascal Girard, Gilles Paintaud
-
Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4
Marion Bouillon-Pichault, Vincent Jullien, Caroline Bazzoli, Gérard Pons, Michel Tod
-
Links between cyclosporin exposure in tissues and graft-versus-host disease in pediatric bone marrow transplantation: analysis by a PBPK model
C. Gerard, Nathalie Bleyzac, Pascal Girard, G. Freyer, Y. Bertrand, M. Tod
-
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkers.
Benjamin Ribba, Emmanuel Watkin, Michel Tod, Pascal Girard, Emmanuel Grenier, Benoît You, Enrico Giraudo, Gilles Freyer
-
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumor.
Benoit You, Ludivine Fronton, Helen Boyle, Jean-Pierre Droz, Pascal Girard, Brigitte Tranchand, Benjamin Ribba, Michel Tod, Sylvie Chabaud, Henri Coquelin, Aude Fléchon
-
Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias.
Benoit You, M. Pollet-Villard, L. Fronton, C. Labrousse, A.-M. Schott, T. Hajri, Pascal Girard, G. Freyer, Michel Tod, B. Tranchand, O. Colomban, Benjamin Ribba, D. Raudrant, J. Massardier, Sylvie Chabaud, F. Golfier
-
Influence of dosing schedule on organ exposure to cyclosporin in pediatric hematopoietic stem cell transplantation: analysis with a PBPK model
C. Gerard, Nathalie Bleyzac, Pascal Girard, G. Freyer, Y. Bertrand, M. Tod
-
Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin's lymphoma
David Ternant, Emilie Henin, Guillaume Cartron, Michel Tod, Gilles Paintaud, Pascal Girard
-
Development of a drug - disease simulation model for rituximab in follicular non-Hodgkin lymphoma
David Ternant, Emilie Henin, Guillaume Cartron, Michel Tod, Gilles Paintaud, Pascal Girard
-
Chemotherapy may be delivered based on an integrated view of tumour dynamics.
Benjamin Ribba, Benoit You, Michel Tod, Pascal Girard, B. Tranchand, V. Trillet-Lenoir, G. Freyer
-
Development of a drug - disease simulation model for rituximab in follicular non-Hodgkin lymphoma
David Ternant, E. Henin, Guillaume Cartron, Michel Tod, Gilles Paintaud, Pascal Girard
-
2009 - Development of a drug-disease simulation model for rituximab in follicular non-Hodgkin lymphoma
David Ternant, E. Henin, Guillaume Cartron, Michel Tod, Gilles Paintaud, Pascal Girard
-
Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.
X. Delavenne, S. Laporte, S. Demasles, N. Mallouk, Michel Tod, Pascal Girard, P. Mismetti
-
Etoposide pharmacokinetics and survival in patients with small cell lung cancer: a multicentre study.
Benoit You, Brigitte Tranchand, Pascal Girard, Claire Falandry, Benjamin Ribba, Sylvie Chabaud, Pierre-Jean Souquet, Isabelle Court-Fortune, Véronique Trillet-Lenoir, Cécile Fournel, Michel Tod, Gilles Freyer